Results 91 to 100 of about 676,913 (315)
Lauterpacht, E. (éd.), International Law : Collected Papers of Hersch Lauterpacht, vol. I : « General Works », vol. II : « The Law of Peace-Part I », vol. III : « The Law of Peace – Part II », London, Cambridge University Press, 1970, 1975 et 1977, xxiii + 539 p. (vol. I) et xxi + 590 p. (vol. II). [PDF]
, 1979 Louise Louthood
openalex +1 more source
Molecular Oncology, EarlyView.Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed +8 more
wiley +1 more source
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
Molecular Oncology, EarlyView.The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias +12 more
wiley +1 more source
What works best in a general practice specific OSCE for medical students: Mini-CEX or content-related checklists? [PDF]
, 2020 Patrick Giemsa +9 more
openalex +1 more source
General practitioners and fitness for work [PDF]
London Journal of Primary Care, 2012 General practitioners (GPs) along with other health and support workers have been assigned an ambiguous, but often crucial, role in decision-making for Employment and Support Allowance (ESA), the replacement for Incapacity Benefit (IB). It is important that GPs understand how ESA works and the help claimant–patients may need.
openaire +3 more sources
Molecular Oncology, EarlyView.Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley +1 more source
General Editors' Preface to Collected Works of Bernard Lonergan [PDF]
, 2000 Frederick E. Crowe, Robert Doran
openalex +1 more source
A general analysis of dalit literature with the references to Bama’s works [PDF]
, 2020 Chhotu Paswan
openalex +1 more source
Molecular Oncology, EarlyView.Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner +6 more
wiley +1 more source
Molecular Oncology, EarlyView.Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva +5 more
wiley +1 more source